Skip to main content

Cartesian Therapeutics, Inc.

RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001453687

No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Cartesian Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of RNAC: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders87180−6
Shares54.0M862.5K54.8M+1.69M (+3.2%)
Value$57.2M$914.3K$37.8M−$18.5M (−32.9%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to RNAC in Q4 2023
InstitutionSharesValue% of portfolio
Millennium Management LLC215,775$148.8K0.00%
Susquehanna International Group, LLP161,045$111.0K0.00%
Virtu Financial LLC88,683$61.0K0.00%
Jane Street Group, LLC85,704$59.1K0.00%
State Board of Administration of Florida Retirement System30,516$21.0K0.00%
Graham Capital Management, L.P.15,789$10.9K0.00%
HRT Financial LP15,053$10.0K0.00%
Engineers Gate Manager LP12,686$8.75K0.00%

Sold out (14)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Not filed for Q4 2023 yet (1)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RNAC in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
OUP Management Co., LLC862,543$914.3K